Song S-K, Lee SH (2019) Cardiomyopathy associated with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome. QJM Mon J Assoc Phys 112(3):213–214
Hirano M, Pavlakis SG (1994) Topical review: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 9(1):4–13. https://doi.org/10.1177/088307389400900102
Article PubMed CAS Google Scholar
Sato W, Tanaka M, Sugiyama S et al (1994) Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am Heart J 128(4):733–774
Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Human Genet 83(2):254–260. https://doi.org/10.1016/j.ajhg.2008.07.004
Pankuweit S, Richter A (2015) Mitochondrial disorders with cardiac dysfunction: an under-reported aetiology with phenotypic heterogeneity. Eur Heart J 36:2894–2897
Wallace DC (2007) Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu Rev Biochem 76:781–821
Meyers DE, Basha HI, Koenig MK (2013) Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J 40:385–394
PubMed PubMed Central Google Scholar
Fayssoil A (2009) Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 15(6):284–287. https://doi.org/10.1111/j.1751-7133.2009.00108.x
Article PubMed CAS Google Scholar
Okajima Y, Tanabe Y, Takayanagi M, Aotsuka H (1998) A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart 80(3):292–295
PubMed PubMed Central CAS Google Scholar
Ito T, Hattori K, Tanaka M et al (1990) Mitochondrial cytopathy. Jpn Circ J 54(9):1214–1220
Wahbi K, Bougouin W, Behin A, Stojkovic T, Becane HM, Jardel C et al (2015) Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases. Eur Heart J 36:2886–2893
Finsterer J, Kothari S (2014) Cardiac manifestations of primary mitochondrial disorders. Int J Cardiol 177:754–763
Stoevesandt D, Schlitt A, Röntgen P, Kraya T (2025) Cardiac manifestations in adult MELAS syndrome (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome)- a cross-sectional study. Orphanet J Rare Dis 20(1):62. https://doi.org/10.1186/s13023-025-03534-5
Article PubMed PubMed Central Google Scholar
Parikh S et al (2017) Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. https://doi.org/10.1038/gim.2017.107
Article PubMed PubMed Central Google Scholar
Koenig MK, Emrick L, Karaa A, Korson M, Scaglia F, Parikh S, Goldstein A (2016) Recommendations for the management of strokelike episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes. JAMA Neurol 73(5):591–594. https://doi.org/10.1001/jamaneurol.2015.5072
Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, De Vivo DC (2007) Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 64(11):1625–1627. https://doi.org/10.1001/archneur.64.11.1625
Malfatti E, Laforet P, Jardel C, Stojkovic T, Behin A, Eymard B et al (2013) High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology 80:100–105
Hendrix CLF, van den Heuvel FMA, Rodwell L, Timmermans J, Nijveldt R, Janssen MCH, Saris CGJ (2022) Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease. Mol Genet Metab 136(3):219–225. https://doi.org/10.1016/j.ymgme.2022.05.004
Article PubMed CAS Google Scholar
Savvatis K, Vissing C, Klouvi L et al (2022) Cardiac outcomes in adults with mitochondrial diseases. J Am Coll Cardiol 80(15):1421–1430. https://doi.org/10.1016/j.jacc.2022.08.716
Gollob MH, Green MS, Tang AS et al (2001) Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344(24):1823–1831
Hardie DG, Carling D (1997) The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem 246(2):259–273
Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, Donati A, Minetti C, Moggio M, Mongini T, Servidei S, Tonin P, Toscano A, Uziel G, Bruno C, Ienco EC, Filosto M, Lamperti C, Catteruccia M, Moroni I, Musumeci O, Pegoraro E, Ronchi D, Santorelli FM, Sauchelli D, Scarpelli M, Sciacco M, Valentino ML, Vercelli L, Zeviani M, Siciliano G (2014) The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol 261(3):504–510
Elorza AA, Soffia JP (2021) MtDNA heteroplasmy at the core of aging-associated heart failure. An integrative view of OXPHOS and mitochondrial life cycle in cardiac mitochondrial physiology. Front Cell Dev Biol 9:625020. https://doi.org/10.3389/fcell.2021.625020
Article PubMed PubMed Central Google Scholar
Nishizawa M, Tanaka K, Shinozawa K, Kuwabara T, Atsumi T, Miyatake T, Ohama E (1987) A mitochondrial encephalomyopathy with cardiomyopathy: a case revealing a defect of complex I in the respiratory chain. J Neurol Sci 78:189–201
Nemoto T, Satoh W, Harada K, Komatsu K, Gotoh A, Matsuno K, Kobayashi Y, Miura Y, Takada G, Ozawa T (1989) Cardiac involvement in four cases of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) [in Japanese with English abstract]. Jpn J Pediatr 93:1416–1421
Hsu YHR, Yogasundaram H, Parajuli N et al (2016) MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev 21:103–116. https://doi.org/10.1007/s10741-015-9524-5
Article PubMed CAS Google Scholar
Bourke JP, Ng YS, Tynan M, Bates MGD, Mohiddin S, Turnbull D, Gorman GS (2022) Arrhythmia prevalence and sudden death risk in adults with the m.3243A>G mitochondrial disorder. Open Heart 9(1):1001819. https://doi.org/10.1136/openhrt-2021-001819
Parikh S, Goldstein A, Koenig MK et al (2013) Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management. Mitochondrion 13:681–687
Comments (0)